Journal
MEDICAL CLINICS OF NORTH AMERICA
Volume 101, Issue 4, Pages 713-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2017.03.004
Keywords
Aspirin; Cardiovascular disease prevention; Colorectal cancer prevention; Guidelines
Categories
Funding
- VA Health Services Research and Development fellowship
- Department of Veterans Affairs
Ask authors/readers for more resources
Aspirin reduces the risk of nonfatal myocardial infarction and stroke, and the risk of colorectal cancer. Aspirin increases the risk of gastrointestinal and intracranial bleeding. The best available evidence supports initiating aspirin in select populations. In 2016, the US Preventive Services Task Force recommended initiating aspirin for the primary prevention of both cardiovascular disease and colorectal cancer among adults ages 50 to 59 who are at increased risk for cardiovascular disease. Adults 60 to 69 who are at increased cardiovascular disease risk may also benefit. There remains considerable uncertainty about whether younger and older patients may benefit.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available